INTRODUCTION
============

Chickens are exposed to many external factors in the course of their life. Factors that may induce stress responses include stocking density, temperature, transport, feed restriction, feed contamination, fear and diseases ([@b38-ajas-28-6-840]; [@b54-ajas-28-6-840]; [@b7-ajas-28-6-840]), which can activate the hypothalamic-pituitary-adrenal axis to enhance the release of glucocorticoids from the adrenal gland ([@b5-ajas-28-6-840]). One of the glucocorticoids is corticosterone that is the primary stress hormone in avian species, including chickens, and stimulates gluconeogenesis to provide the body with more energy when birds encounter stressful situations ([@b5-ajas-28-6-840]).

Corticosterone has been frequently used as a tool of inducing stress responses to study the effects of stress in chickens. For example, daily administrations of corticosterone cause responses such as increased feed and water consumptions, reduced energy absorptive efficiency, suppressed growth rate, enhanced proteolysis and gluconeogenesis in broilers ([@b52-ajas-28-6-840]; [@b27-ajas-28-6-840]). Similar results were found in young male chicks treated with cortisol showing decreased growth rate and increased muscle breakdown ([@b4-ajas-28-6-840]). With reduced body weight gain and increased food intake, abdominal and liver fat masses were notably increased in broilers treated with corticosterone ([@b2-ajas-28-6-840]).

In laying hens, corticosterone causes increased feed intake, reduced weight gain, elevated corticosterone concentrations and heterophil/lymphocyte ratios, higher feather picking, longer tonic immobility, and reduced immune functions ([@b10-ajas-28-6-840]; [@b51-ajas-28-6-840]), in addition to increased weights of the liver and the abdominal fat pad ([@b41-ajas-28-6-840]). Furthermore, corticosterone administration delayed the onset of egg laying and shorted the duration of peak production, thereby reduced hen day egg production ([@b51-ajas-28-6-840]). Remarkable reduction has been observed in the weights of the oviduct and ovary in these hens ([@b41-ajas-28-6-840]; [@b51-ajas-28-6-840]) or in the hens subject to induced molting ([@b53-ajas-28-6-840]). Consistent with these observations is that a large number of atretic follicles were observed in the ovary of these hens, but not in control ([@b37-ajas-28-6-840]). Through these effects, corticosterone treatment may have contributed to both reduced egg mass and altered plasma steroidal hormone concentrations ([@b17-ajas-28-6-840]), perhaps thereby leading to decreased fertility and hatchability of eggs while increasing the number of early dead embryos in eggs laid by highly stress-sensitive quail hens ([@b49-ajas-28-6-840]).

Although many aspects of responses to corticosterone treatments have been to date investigated in laying hens ([@b41-ajas-28-6-840]; [@b10-ajas-28-6-840]; [@b49-ajas-28-6-840]; [@b51-ajas-28-6-840]; [@b17-ajas-28-6-840]), little is known about how dietary corticosterone affects egg quality such as yolk colors. The objective of this study was to determine the effects of dietary corticosterone on egg quality in laying hens, with special reference to yolk colors and eggshell quality.

MATERIALS AND METHODS
=====================

Animal husbandry
----------------

Forty, 47 week-old Single Comb Brown Hy-Line Leghorn laying hens were housed in individual cages in a room with a constant ambient temperature (20±2°C) and a 15 h light:9 h dark cycle (lights on at 06:00 h) throughout the experimental period. They had free access to a commercial layer diet (Nonghyup Feed Co., Ltd., Seoul, Korea) and tap water for the first 2 weeks as the adaptation period, at the end of which hens were divided into two groups (n = 20 each) and provided with either control or experimental diet for the next two weeks. In order to produce the experimental diet, corticosterone (92%, \#C2505, Sigma-Aldrich Co., St. Louis, MO, USA), dissolved completely in 100% ethanol (2.61 mg/mL), was mixed with feed using a mixer for 30 min, consequently yielding 30 mg corticosterone per kg diet. For control diet, the same amount of ethanol as one used in the experimental diet was added to the feed and was mixed for 30 min. This procedure made no alcohol left in the diet. Feed intake and egg production were monitored daily in the morning, and body weight was measured weekly throughout the experimental period. This study was approved by the Institutional Animal Use and Care Committee of Gyeongsang National University.

Egg quality
-----------

Egg quality on days 0, 1, 5, and 10 were measured within 24 h after the collection for egg weight, albumen height, Haugh unit (HU), shell weight, shell color, and yolk colors with QCM+ (TSS, York, England). Eggshell thickness (without the inner and outer shell membranes) was measured using a micrometer (Mitutoyo Co., Ltd., Kawasaki, Japan). Shell strength was measured using an FHK eggshell strength tester (Fugihira Industry Co., Ltd., Tokyo, Japan) by fixing the sharp edge of the egg to come down, and yolk colors were determined using a yolk color fan (BASF Co., Ltd., Monheim, Germany).

Blood biochemical analysis
--------------------------

At the end of the entire experiment, blood was collected into vacutainers containing heparin (\#367874, BD Co., Ltd., Franklin Lakes, NJ, USA) from the trunk of birds after decapitation with a guillotine. After the blood samples were centrifuged at 2,000×*g* at 4°C for 10 min, plasma was decanted into new tubes which were stored at --20°C until later analysis. Blood biochemicals were measured using a VetTest Chemistry Analyzer (IDEXX Co., Ltd., Westbrook, ME, USA) with a dry-slide technology. Plasma corticosterone concentrations were determined in duplicates using an ELISA kit (\#ADI-901-097, Enzo Life Sciences, Farmingdale, NY, USA).

Statistical analyses
--------------------

All data were represented as mean±standard error of the mean. A Student's t-test was performed using Microsoft Excel to assess differences between control and corticosterone-treatment groups at p≤0.05.

RESULTS
=======

Performance
-----------

No hens were found dead through the entire experiment. Dietary corticosterone administration resulted in significant increase in feed intake by up to 39% for 14 days (p\<0.05), but no significant changes (p\>0.05) in weekly body weights, compared with control. In corticosterone-treated hens, egg production started to plunge by approximately 30% around day 5 and reached nearly 0% around day 11 whereas control maintained around 90% ([@b21-ajas-28-6-840]).

Egg quality
-----------

Egg weight, eggshell weight, shell color and shell strength were not different (p\>0.05), but shell thickness was significantly increased by corticosterone on days 1 and 10 compared with control (p\<0.05) ([Figure 1](#f1-ajas-28-6-840){ref-type="fig"}). By corticosterone treatment, albumen height and thereby HU were significantly decreased in eggs produced on day 10. Significant increase in yolk colors was observed in corticosterone-treated group on days 1 and 10 (p\<0.05). In particular, yolk redness was gradually increased by corticosterone over the time, reaching significant differences on days 5 and 10 (p\<0.05) ([Figure 2](#f2-ajas-28-6-840){ref-type="fig"}), but both yellowness and lightness were either not significantly different or inconsistent between two groups.

Blood biochemical analysis
--------------------------

Plasma concentrations of biochemicals are shown in [Table 1](#t1-ajas-28-6-840){ref-type="table"}. Plasma corticosterone concentrations were significantly higher in corticosterone-treated group, compared with control (p\<0.05). Increased concentrations were found for corticosterone, glucose, cholesterol, creatinine, uric acid, albumin, aspartate aminotransferase (AST), creatine kinase (CK), lactate dehydrogenase (LDH), total protein (TP), and amylase in plasma of hens treated with corticosterone (p\<0.05) while those for triglyceride and calcium were decreased (p\<0.05). Corticosterone treatment failed to affect ammonia, phosphorus, and globulin concentrations in plasma.

DISCUSSION
==========

The present results show that despite enhanced feed intake, which is similar to those found in previous studies ([@b3-ajas-28-6-840]; [@b52-ajas-28-6-840]), dietary corticosterone did not affect body weight in laying hens. Rather, corticosterone treatments have been reported to decline body weight in broilers ([@b19-ajas-28-6-840]; [@b55-ajas-28-6-840]) and laying hens ([@b10-ajas-28-6-840]; [@b51-ajas-28-6-840]; [@b30-ajas-28-6-840]). Corticosterone treatments also decrease feed and caloric efficiencies ([@b22-ajas-28-6-840]; [@b29-ajas-28-6-840]; [@b8-ajas-28-6-840]; [@b19-ajas-28-6-840]; [@b55-ajas-28-6-840]), which is associated with enhanced energy expenditure, proteolysis and gluconeogenesis ([@b4-ajas-28-6-840]; [@b27-ajas-28-6-840], [@b28-ajas-28-6-840]). Elevated release of corticosterone from the adrenal cortex in response to stressful stimuli has been proposed to promote gluconeogenesis to increase plasma glucose concentrations and lipolysis to break down fat tissues to provide the bird with more energy ([@b48-ajas-28-6-840]). Increased feed intake by dietary corticosterone may have been another factor contributing to changes in blood glucose and protein concentrations. But these changes are likely to be secondary, rather than primary, effect on those parameters, because although feed intake was decreased, plasma concentrations of glucose and uric acid were increased in broilers treated with dietary administration of corticosterone ([@b27-ajas-28-6-840]).

Corticosterone treatments also led to decreased egg production in laying hens, and resulted in elevated concentrations of corticosterone in plasma which is associated with reduced daily egg production in hens ([@b24-ajas-28-6-840]; [@b51-ajas-28-6-840]) by delaying the onset of egg laying and shortening the period of peak production ([@b51-ajas-28-6-840]). It seems that corticosterone decreases egg production by way of affecting energy metabolism with reduced feed and calorie efficiencies ([@b55-ajas-28-6-840]) and by reducing weights of the ovary and oviduct of laying hens ([@b51-ajas-28-6-840]).

Studies have shown that heat stress reduces egg production, egg weight, shell weight and shell thickness in laying hens ([@b36-ajas-28-6-840]; [@b35-ajas-28-6-840]), and similar results were found in egg-laying ducks ([@b34-ajas-28-6-840]). In the current study, shell thickness, but not shell weight and shell strength, was significantly increased by corticosterone compared with control, suggesting an altered structure in egg shell induced by elevated corticosterone. High plasma corticosterone concentrations play a critical role in eggshell formation depending on the time of egg laying ([@b23-ajas-28-6-840]). Indeed, dexamethasone, a synthetic glucocorticoid, has been shown to prolong the period of egg formation and to reduce the expression of calbindin mRNA in the eggshell gland and the intestine ([@b1-ajas-28-6-840]) and c-myc mRNA in the oviduct ([@b45-ajas-28-6-840]). Expression of calbindin occurs after that of osteopontin, both of which plays a role in calcification, and soft shells are accompanied by reduced expression in calbindin, but not in osteopontin ([@b25-ajas-28-6-840]).

Corticosterone treatment altered yolk colors in the current study. Redness in yolk colors was gradually increased in eggs laid on days 5 and 10 from corticosterone-treated hens, but lightness was not consistent over the time period of measurements. These changes resulted in slight but significant increase in yolk colors. Yolk colors are affected by feed components ([@b44-ajas-28-6-840]; [@b13-ajas-28-6-840]). Mother hens regularly deposit nutrients and xanthophyll into eggs ([@b40-ajas-28-6-840]). As corticosterone-treated hens consumed more feed, but laid eggs fewer compared with control in this study, reduced egg production by corticosterone may have contributed at least in part to enhanced redness in yolk colors.

Corticosterone deteriorates egg freshness as shown by reduced HU in this study. HU has been used for long as an indicator of egg freshness which is expressed as relationship of egg weight and albumen height ([@b14-ajas-28-6-840]). In the current study, corticosterone failed to affect egg weight but did decrease albumen height on day 10, thereby resulting in reduced HU. Stress such as heat stress decreased HU in addition to egg production, egg weight, eggshell strength and eggshell thickness in laying ducks ([@b34-ajas-28-6-840]). However, stock density shows different effects depending upon experimental methods. Increasing stock density resulted in decreased HU but no change in shell thickness ([@b39-ajas-28-6-840]), or no effects on HU and shell thickness ([@b6-ajas-28-6-840]). Nutritional modulation of stress has been indicative of varying results: dietary betaine resulted in no changes in HU, albumen weight, and egg specific gravity but increased egg production when hens reared under high air ammonia conditions ([@b12-ajas-28-6-840]). On the other hand, dietary humate decreased HU without affecting shell thickness and strength, but increased egg production, feed consumption, and feed conversion ratio when hens were housed in high density ([@b15-ajas-28-6-840]).

High plasma corticosterone concentrations appear to be associated with reduced egg quality in the current study. Effects of corticosterone on egg quality have been observed across avian species. Previous studies have reported that maternal stress can increase corticosterone content in eggs of great tits ([@b42-ajas-28-6-840]), with lower maternal condition being associated with higher deposition of yolk corticosterone in European starlings ([@b32-ajas-28-6-840]). Maternally increased corticosterone has been shown to result in female-biased hatching sex ratios caused by elevated male embryonic mortality, lighter male offspring at hatching and subsequently retarded growth during postnatal development, and lower cell-mediated immune responses in males of European starlings ([@b31-ajas-28-6-840]). Furthermore, direct injections of corticosterone into eggs resulted in increased embryo mortality, earlier termination of fetal development, and reduced growth rates after hatching in chickens ([@b11-ajas-28-6-840]), and in greater loss of egg mass, reduced immunity and altered behavior in offspring of yellow-legged gulls ([@b46-ajas-28-6-840]). Similar results were also observed in Japanese quail showing that elevating maternal corticosterone causes reduced growth rate and abnormal behavior of their offspring ([@b16-ajas-28-6-840]). As corticosterone in the blood circulation is transferred into the albumen and yolk of the eggs, corticosterone concentrations of albumen were increased in the eggs from stressed hens than control eggs in barn swallows ([@b47-ajas-28-6-840]) and laying hens ([@b9-ajas-28-6-840]). Corticosterone concentrations in egg albumen has been suggested as a non-invasive indicator of stress in laying hens, as indicated by the facts that higher corticosterone concentrations in albumen can affect phenotype and embryonic development of offspring ([@b47-ajas-28-6-840]) and that plasma corticosterone concentrations are positively related with albumen corticosterone concentrations ([@b9-ajas-28-6-840]). Stressed mothers lay eggs with high corticosterone levels which lead to low-quality offspring ([@b47-ajas-28-6-840]).

The present study shows that dietary corticosterone resulted in significant increase in glucose, cholesterol, albumin, creatinine, uric acid, amylase, AST, LDH, and TP concentrations in plasma, with the tendency to increase CK (p\<0.0503) and globulin (p\<0.075), and in significant decrease in triglyceride and Ca^2+^, but no changes in ammonia, phosphorus and magnesium. Similar results have been reported in laying hens after either adrenocorticotropic hormone (ACTH) infusion ([@b37-ajas-28-6-840]) or chronic corticosterone administrations ([@b51-ajas-28-6-840]), and in broilers after ACTH administration ([@b43-ajas-28-6-840]). In the current study, triglyceride concentrations were decreased by corticosterone, opposite to previous studies using corticosterone, heat stress or lipopolysaccharide administration ([@b26-ajas-28-6-840]; [@b50-ajas-28-6-840]).

With the TP being increased in plasma, the present results suggest that dietary corticosterone has contributed to increased protein breakdown, renal dysfunctions, and pancreatitis. An increased muscle proteolysis resulted in greater uric acid concentrations in plasma of broilers treated with dietary corticosterone ([@b27-ajas-28-6-840]). Prolonged starvation also causes to increase uric acid in plasma, which is associated with increased proteolysis, plasma corticosterone, and body mass loss, but with decreased plasma β-hydroxybutyrate reflecting a decreased contribution of lipids to energy metabolism ([@b33-ajas-28-6-840]). Renal dysfunctions are other factors leading to elevated concentrations of plasma nonprotein nitrogen such as uric acid, creatinine and urea ([@b33-ajas-28-6-840]). Increased amylase and lipase activities in plasma appear to be related to pancreatitis ([@b20-ajas-28-6-840]; [@b18-ajas-28-6-840]). Increased concentrations of enzymes such as AST, LDH, and CK have been considered as indicators of recent organ damage rather than decreased organ functions or muscle damage ([@b18-ajas-28-6-840]; [@b33-ajas-28-6-840]).

Taken together, the results of the current study imply that dietary corticosterone affects egg quality such as yolk colors and shell thickness, in addition to its effects on feed intake and egg production.
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Effects of dietary corticosterone on plasma concentrations of corticosterone, glucose, cholesterol, triglyceride, ammonia, albumin, creatinine, globulin, total protein, uric acid, amylase, aspartate aminotransferase, creatine kinase, lactate dehydrogenase, magnesium, calcium and phosphorus in laying hens

  Parameters                           CON            CORT           p-value
  ------------------------------------ -------------- -------------- ---------
  Corticosterone (ng/mL)               13.1 ±1.0      18.3 ±1.2      0.02
  Glucose (mg/dL)                      260.7 ±6.57    319.2 ±19.3    0.005
  Cholesterol (mg/dL)                  93.5 ±9.74     229.2 ±20.4    0
  Triglyceride (mg/dL)                 365.8 ±7.5     200.4 ±43.7    0.001
  Ammonia (μmol/L)                     139 ±16.6      182.2 ±29.7    0.105
  Albumin (g/dL)                       1.6 ±0.16      2.1 ±0.05      0.007
  Creatinine (mg/dL)                   0.06 ±0.03     0.2 ±0.04      0.012
  Globulin (mg/dL)                     3.3 ±0.22      3.7 ±0.14      0.075
  Total protein (mg/dL)                4.9 ±0.30      6.0 ±0.21      0.007
  Uric acid (mg/dL)                    5.4 ±0.95      11.5 ±0.05     0.001
  Amylase (U/L)                        193.2 ±31.7    268.5 ±21.42   0.046
  Aspartate aminotransferase (U/L)     156.6 ±20.6    262 ±7.6       0.007
  Creatine kinase (×10^3^ U/L)         446.5 ±131.8   930.5 ±249.1   0.050
  Lactate dehydrogenase (×10^3^ U/L)   1,181 ±193     2,110 ±423.5   0.026
  Calcium (mg/dL)                      15.5 ±0.39     11.9 ±0.78     0.001
  Magnesium (mg/dL)                    3.5 ±0.39      3.0 ±0.13      0.152
  Phosphorus (mg/dL)                   5.1 ±0.45      5.3 ±0.54      0.383

Laying hens were provided for 14 days with either control (CON) or experimental diet (CORT) containing corticosterone at 30 mg/kg diet.

Data show means±standard error of the mean (n = 8).
